Literature DB >> 10404064

Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing.

J G Park1, Y J Park, J T Wijnen, H F Vasen.   

Abstract

Hereditary nonpolyposis colorectal cancer (Lynch syndrome) is an autosomal dominant disease caused by mutations in the mismatch repair genes in particular in MLH1, MSH2 and MSH6. The disease is characterized by the development of colorectal, endometrial cancer and several other cancers. There is evidence that the clinical expression of the disease varies from one country to another. This variation might affect not only the application of criteria proposed to identify families but also clinical risk factors reported to predict the outcome of genetic testing. Data on site of the cancer, age at diagnosis and pathology were collected from 155 families with suspected HNPCC known at the Korean and Dutch HNPCC registries. DGGE, SSCP and DNA-sequencing were performed to identify MSH2, MLH1 and MSH6 mutations. A total of 33 Korean and 42 Dutch families met the clinical criteria for HNPCC. Germline mutations in the MMR-genes were found in 23 Korean and 24 Dutch families. In families that met the Amsterdam criteria, and also in those associated with MLH1 mutations, more cancers of the stomach and pancreas were observed in the Korean families than in the Dutch HNPCC families; in relative terms, the incidence of cancers of the endometrium in the Korean families was lower. Multivariate analysis showed that an early age at diagnosis, and the occurrence of pancreatic cancer were independent predictive factors of germline mutations in MLH1, MSH2 and MSH6 in the Korean subset of families. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404064     DOI: 10.1002/(sici)1097-0215(19990812)82:4<516::aid-ijc8>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

Authors:  Andrea Mann; Estrid Hogdall; Susan J Ramus; Richard A DiCioccio; Claus Hogdall; Lydia Quaye; Valerie McGuire; Alice S Whittemore; Mitul Shah; David Greenberg; Douglas F Easton; Bruce A J Ponder; Susanne Krüger Kjaer; Simon A Gayther; Deborah J Thompson; Paul D P Pharoah; Honglin Song
Journal:  Eur J Cancer       Date:  2008-08-22       Impact factor: 9.162

2.  Is prostate cancer a Lynch syndrome cancer?

Authors:  Aung Ko Win
Journal:  Asian J Androl       Date:  2013-07-01       Impact factor: 3.285

3.  Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

Authors:  Alexandra Snyder; Peter Allen; Ali Shamseddine; Ali Haydar; Mohamed Eloubeidi; Walid Faraj; Mohamed Khalife; Sally Temraz; Ashwaq El-Olayan; David P Kelsen; Fadi El-Merhi; Mohamed Naghy; Leonard B Saltz; Ghassan K Abou-Alfa; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-09

Review 4.  Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].

Authors:  H F A Vasen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 5.  Physical activity in the prevention and treatment of colorectal carcinoma.

Authors:  Martin Halle; Michael H Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2009-10-30       Impact factor: 5.594

6.  Is surveillance of the small bowel indicated for Lynch syndrome families?

Authors:  G L ten Kate; J H Kleibeuker; F M Nagengast; M Craanen; A Cats; F H Menko; H F A Vasen
Journal:  Gut       Date:  2007-04-04       Impact factor: 23.059

7.  Risk factors for pancreatic adenocarcinoma and prospects for screening.

Authors:  G Anton Decker; Mashal J Batheja; Joseph M Collins; Alvin C Silva; Kristin L Mekeel; Adyr A Moss; Cuong C Nguyen; Douglas F Lake; Laurence J Miller
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

8.  Colonoscopy screening for individuals aged 40-49 years with a family history of stomach cancer in Korea.

Authors:  Yong Sung Choi; Jung Pil Suh; Doo Seok Lee; Eui Gon Youk; In Taek Lee; Suk Hee Lee; Do Sun Kim; Doo Han Lee
Journal:  Int J Colorectal Dis       Date:  2009-12-11       Impact factor: 2.571

Review 9.  Cancer risk in mismatch repair gene mutation carriers.

Authors:  P Watson; H T Lynch
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations.

Authors:  P Peltomäki; X Gao; J P Mecklin
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.